S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
OTCMKTS:CHEOY

Cochlear Stock Forecast, Price & News

$80.02
+0.48 (+0.60 %)
(As of 10/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$80.02
$80.02
50-Day Range
$76.38
$94.05
52-Week Range
$68.00
$94.21
Volume814 shs
Average Volume2,012 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CHEOY News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.


Cochlear logo

About Cochlear

Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CHEOY
Employees
4,000
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Next Earnings Date
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.77 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Cochlear (OTCMKTS:CHEOY) Frequently Asked Questions

Is Cochlear a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cochlear in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Cochlear stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CHEOY, but not buy additional shares or sell existing shares.
View analyst ratings for Cochlear
or view top-rated stocks.

What stocks does MarketBeat like better than Cochlear?

Wall Street analysts have given Cochlear a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cochlear wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Cochlear?

Cochlear saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 100 shares, a decrease of 66.7% from the August 31st total of 300 shares. Based on an average daily volume of 2,000 shares, the days-to-cover ratio is currently 0.1 days.
View Cochlear's Short Interest
.

How has Cochlear's stock been impacted by COVID-19 (Coronavirus)?

Cochlear's stock was trading at $60.24 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CHEOY stock has increased by 32.8% and is now trading at $80.02.
View which stocks have been most impacted by COVID-19
.

How often does Cochlear pay dividends? What is the dividend yield for Cochlear?

Cochlear announced a dividend on Thursday, September 16th. Investors of record on Thursday, September 23rd will be paid a dividend of $0.9535 per share on Tuesday, November 2nd. This represents a yield of 1.13%. The ex-dividend date of this dividend is Wednesday, September 22nd. This is a positive change from Cochlear's previous dividend of $0.45.
View Cochlear's dividend history
.

Who are Cochlear's key executives?

Cochlear's management team includes the following people:
  • Diggory William Howitt, President, CEO, Executive Director & MD
  • Stuart Sayers, Chief Financial Officer & President-Services
  • Jan Janssen, Chief Technology Officer
  • David Hackshall, Chief Information Officer
  • Matthew Prior, VP-Finance & Commercial Operations-Asia Pacific

What is Cochlear's stock symbol?

Cochlear trades on the OTCMKTS under the ticker symbol "CHEOY."

How do I buy shares of Cochlear?

Shares of CHEOY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cochlear's stock price today?

One share of CHEOY stock can currently be purchased for approximately $80.02.

How many employees does Cochlear have?

Cochlear employs 4,000 workers across the globe.

What is Cochlear's official website?

The official website for Cochlear is www.cochlear.com.

Where are Cochlear's headquarters?

How can I contact Cochlear?

Cochlear's mailing address is 1 University Avenue, Sydney, New South Wales 2109. The company can be reached via phone at (129) 428-6555.


This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.